Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Walmar Clinical ApS
APS
Active
CVR 43237381
Stolbjergvej 26C
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 1,9M
+2% vs 2023
EBITDA margin
41.1%
+3% vs 2023
Equity ratio
27.5%
Financial strength
Net profit 2024
DKK 623K
-14% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 1,9M
+2%
EBITDA
DKK 800K
+3%
Net profit
DKK 623K
-14%
Total assets
DKK 2,4M
+14%
Equity
DKK 666K
-14%
Employees
2
—
Company information
Legal name
Walmar Clinical ApS
CVR number
43237381
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3. maj 2022
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Stolbjergvej 26C
Phone
+4541904422
Email
mikkel@walmarclinical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Helsingør
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
1M
2022
2M
2023
2M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
1.125
1.910
1.946
Staff expenses
-391
-1.135
-1.146
EBITDA
733
775
800
Depreciation & amort.
-0
-0
-0
EBIT
733
775
800
Net financials
49
156
-1
Profit before tax
782
931
800
Tax
172
206
176
Net profit
610
725
623
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
969
2.121
2.419
Equity
650
775
666
Long-term debt
0
0
0
Short-term debt
319
1.346
1.753
Total debt
319
1.346
1.753
Financial ratios
5-year trend
EBITDA margin
41.1%
This company
15.8%
Market median
+160% vs market
2022
2024
Equity ratio
27.5%
This company
38.2%
Market median
-28% vs market
2022
2024
Return on equity
93.6%
This company
18.4%
Market median
+409% vs market
2022
2024
Net profit margin
32.0%
This company
8.1%
Market median
+295% vs market
2022
2024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
2022
2024
Debt / equity
2.63×
This company
0.62×
Market median
-324% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-05-03 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
PG
Pernille Gry Hansen
Founder
Founder
2022
—
—
MW
Mikkel Walmar
Management
Management
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
26c Holding ApS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
26c Holding ApS
Walmar Clinical ApS
(this company)
Board network connections
Board members of Walmar Clinical ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Pernille Gry Hansen
Founder
0 companies
Mikkel Walmar
Management
0 companies